Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy

被引:44
作者
Cheng, Hui Lin [1 ]
Lopez, Violeta [2 ]
Lam, Simon Ching [1 ]
Leung, Anthony Kwun To [3 ]
Li, Yu Chung [3 ]
Wong, Kam Hung [3 ]
Au, Joseph Siu Kie [4 ]
Sundar, Raghav [5 ]
Chan, Alexandre [6 ]
De Ng, Terrence Rong [6 ]
Suen, Lorna Kwai Ping [1 ]
Chan, Choi Wan [1 ]
Yorke, Janelle [7 ]
Molassiotis, Alex [1 ]
机构
[1] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China
[2] Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Singapore, Singapore
[3] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China
[4] Hong Kong Adventist Hosp, Dept Oncol, Hong Kong, Peoples R China
[5] Natl Univ Hlth Syst, Dept Haematol Oncol, Singapore, Singapore
[6] Natl Univ Singapore, Dept Pharm, Singapore, Singapore
[7] Univ Manchester, Div Nursing Midwifery & Social Work, Manchester, Lancs, England
关键词
Chemotherapy; Peripheral neuropathy; FACT; GOG-Ntx; EORTC QLQ-CIPN20; Psychometrics; Responsiveness; Confirmatory factor analysis; INDUCED PERIPHERAL NEUROPATHY; QUESTIONNAIRE; SURVIVORS; QUALITY; VALIDATION; MANAGEMENT; LIFE;
D O I
10.1186/s12955-020-01493-y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The aim of this study was to evaluate the psychometric properties of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Methods Patients were assessed with the FACT/GOG-Ntx subscale, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Chemotherapy-Induced Peripheral Neuropathy Scale 20 (EORTC QLQ-CIPN20), National Cancer Institute -Common Terminology Criteria for Adverse Events (NCI-CTCAE), and light touch test using 10 g monofilament for up to ten assessment points from baseline (prior to initiation of first chemotherapy), after the end of each cycle (up to 6 cycles, 3 weeks per cycle), and at 6, 9, and 12 months after starting chemotherapy. Psychometric analyses included internal consistency reliability, convergent validity, factorial validity, sensitivity to change and responsiveness (minimal clinically important difference, MCID). Results Cronbach's alpha coefficients of the FACT/GOG-Ntx subscale were 0.82-0.89 across assessment points. The subscale strongly correlated with the EORTC QLQ-CIPN20 (r = 0.79-0.93) but low-to-moderately correlated with the NCI-CTCAE sensory (r(s) = 0.23-0.45) and motor items (r(s) = 0.15-0.50) as well as the monofilament test (r(s) = 0.23-0.47). The hypothesized 4-factor structure of the FACT/GOG-Ntx subscale was not confirmed at assessment points (chi 2/df = 2.26-8.50; allP < 0.001). The subscale exhibited small-to-moderate sensitivity to change (r = 0.17-0.37). The MCIDs were between 1.38 and 3.68. Conclusion The FACT/GOG-Ntx subscale has satisfactory reliability, validity, sensitivity to change and responsiveness to evaluate CIPN in cancer patients. Future research is needed to explore the factorial structure of the FACT/GOG-Ntx subscale as the published four-factor structure was not supported in this study.
引用
收藏
页数:9
相关论文
共 34 条
[1]  
[Anonymous], 2010, COMM TERM CRIT ADV E
[2]   Using generalized estimating equations for longitudinal data analysis [J].
Ballinger, GA .
ORGANIZATIONAL RESEARCH METHODS, 2004, 7 (02) :127-150
[3]   Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy [J].
Calhoun, EA ;
Welshman, EE ;
Chang, CH ;
Lurain, JR ;
Fishman, DA ;
Hunt, TL ;
Cella, D .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (06) :741-748
[4]   The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings [J].
Cavaletti, G. ;
Cornblath, D. R. ;
Merkies, I. S. J. ;
Postma, T. J. ;
Rossi, E. ;
Frigeni, B. ;
Alberti, P. ;
Bruna, J. ;
Velasco, R. ;
Argyriou, A. A. ;
Kalofonos, H. P. ;
Psimaras, D. ;
Ricard, D. ;
Pace, A. ;
Galie, E. ;
Briani, C. ;
Dalla Torre, C. ;
Faber, C. G. ;
Lalisang, R. I. ;
Boogerd, W. ;
Brandsma, D. ;
Koeppen, S. ;
Hense, J. ;
Storey, D. ;
Kerrigan, S. ;
Schenone, A. ;
Fabbri, S. ;
Valsecchi, M. G. .
ANNALS OF ONCOLOGY, 2013, 24 (02) :454-462
[5]   Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools [J].
Cavaletti, Guido ;
Frigeni, Barbara ;
Lanzani, Francesca ;
Mattavelli, Laura ;
Susani, Emanuela ;
Alberti, Paola ;
Cortinovis, Diego ;
Bidoli, Paolo .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (03) :479-494
[6]   Measuring the side effects of taxane therapy in oncology - The functional assessment of cancer therapy-taxane (FACT-taxane) [J].
Cella, D ;
Peterman, A ;
Hudgens, S ;
Webster, K ;
Socinski, MA .
CANCER, 2003, 98 (04) :822-831
[7]   Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Cancer-Gynecologic Oncology Group-Neurotoxicity subscale (FACT/GOG-Ntx) [J].
Cheng, Hui Lin ;
Molassiotis, Alex .
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (01) :56-62
[8]   A POWER PRIMER [J].
COHEN, J .
PSYCHOLOGICAL BULLETIN, 1992, 112 (01) :155-159
[9]   Evaluation of the Semmes-Weinstein filaments and a questionnaire to assess chemotherapy-induced peripheral neuropathy [J].
da Silva Simao, Delma Aurelia ;
Teixeira, Antonio Lucio ;
Souza, Raissa Silva ;
Ribeiro de Paula Lima, Elenice Dias .
SUPPORTIVE CARE IN CANCER, 2014, 22 (10) :2767-2773
[10]   Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer [J].
Frisina, Robert D. ;
Wheeler, Heather E. ;
Fossa, Sophie D. ;
Kerns, Sarah L. ;
Fung, Chunkit ;
Sesso, Howard D. ;
Monahan, Patrick O. ;
Feldman, Darren R. ;
Hamilton, Robert ;
Vaughn, David J. ;
Beard, Clair J. ;
Budnick, Amy ;
Johnson, Eileen M. ;
Ardeshir-Rouhani-Fard, Shirin ;
Einhorn, Lawrence H. ;
Lipshultz, Steven E. ;
Dolan, M. Eileen ;
Travis, Lois B. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (23) :2712-+